Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00802945
What this trial is testing

Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
TumorBreast Cancer
Nektar Therapeutics 70
Testing effectiveness (Phase 2)Study completedNCT00191672
What this trial is testing

A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eli Lilly and Company 120
Testing effectiveness (Phase 2)Study completedNCT00118157
What this trial is testing

Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen

Who this might be right for
Estrogen Receptor PositiveMale Breast CarcinomaProgesterone Receptor Positive+4 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Looking for participantsNCT05989828
What this trial is testing

A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
University of Southern California 20
Testing effectiveness (Phase 2)Study completedNCT00087958
What this trial is testing

Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment

Who this might be right for
Breast Cancer
Sanofi 168
Large-scale testing (Phase 3)Looking for participantsNCT07294508
What this trial is testing

Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer

Who this might be right for
HER2 + Breast Cancer
Shanghai Henlius Biotech 706
Testing effectiveness (Phase 2)Looking for participantsNCT07299825
What this trial is testing

A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

Who this might be right for
Her 2 Positive Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT02481050
What this trial is testing

Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Eisai Inc. 58
Not applicableStudy completedNCT05361655
What this trial is testing

Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor

Who this might be right for
Metastatic Breast Cancer
Pfizer 2,888
Early research (Phase 1)Study completedNCT00140738
What this trial is testing

Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 3
Testing effectiveness (Phase 2)Ended earlyNCT00138125
What this trial is testing

Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Translational Oncology Research International 2
Not applicableNot Yet RecruitingNCT05480189
What this trial is testing

Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study

Who this might be right for
Histologically Confirmed Breast Cancer ,Diagnosis of Bone Metastasis
Zhejiang Cancer Hospital 1,000
Early research (Phase 1)Looking for participantsNCT05372640
What this trial is testing

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma+5 more
National Cancer Institute (NCI) 45
Not applicableLooking for participantsNCT07067138
What this trial is testing

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Who this might be right for
Breast CancerBreast CarcinomaCancer of the Breast+1 more
National Cancer Institute (NCI) 175
Not applicableActive Not RecruitingNCT02965755
What this trial is testing

Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins

Who this might be right for
Metastatic Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 200
Testing effectiveness (Phase 2)Ended earlyNCT03952325
What this trial is testing

Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC

Who this might be right for
Breast Cancer
Odonate Therapeutics, Inc. 294
Testing effectiveness (Phase 2)Ended earlyNCT01703754
What this trial is testing

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.

Who this might be right for
Breast Cancer Nos Metastatic Recurrent
Alaunos Therapeutics 12
Not applicableStudy completedNCT05577156
What this trial is testing

SexoMBC2 Non Interventional Study

Who this might be right for
Breast CancerQuality of LifeSexual Behavior
Institut de Cancérologie de Lorraine 48
Not applicableStudy completedNCT06305702
What this trial is testing

Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast Cancer
Liaoning Cancer Hospital & Institute 500
Large-scale testing (Phase 3)Study completedNCT01986569
What this trial is testing

Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CancerStage IV Breast Cancer
Asan Medical Center 93
Next Page